Non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 (inclusive); 2. Patients with pathologically diagnosed non-small cell lung cancer, who are in stages III-IV according to TNM staging, are scheduled to undergo chemotherapy; they are planned to receive at least two cycles of standardized chemotherapy regimen; 3. Meet the diagnostic criteria of CRF; 4. Karnofsky functional status score = 60; 5. Patients who receive standard chemotherapy regimens: TP regimen (paclitaxel + cisplatin/carboplatin) or DP regimen (docetaxel + cisplatin/carboplatin) chemotherapy, with the chemotherapy regimen in accordance with the recommended dosage and cycle as per the 2025 CSCO Guidelines for the Diagnosis and Treatment of Primary Non-Small Cell Lung Cancer; 6. Those with an expected survival period of more than 3 months; 7. Voluntarily sign the informed consent form and be willing to cooperate in completing the study.
Exclusion criteria
Exclusion criteria: 1. Those with damaged, infected, or allergic skin at the acupoints where wheat grain moxibustion is applied; 2. Patients with combined severe dysfunction of vital organs such as the heart, liver, and kidneys; 3. Patients with mental illness who are unable to cooperate; 4. Those who are currently participating in other clinical trials that may affect immune function; 5. Pregnant or lactating women; 6. Individuals with an allergy to tobacco smoke.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cancer-related fatigue severity scoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical Condition Rating;Quality of Life;Anxiety and depressive mood;Insomnia severity;Predefined Cycle Chemotherapy Completion Rate; | — |
Countries
China
Contacts
Shanxi University of Traditional Chinese Medicine Affiliated Acupuncture Hospital